WANG Xianyan, GONG Lansheng, GUO Jizhen, WANG Xiaoming, LIU Yuhui, YE Xuying, ZHANG Guoyuan, YANG Peilin. Multicenter Parallel Study of Amlodipine Versus Nitrendipine in Treatment Essential HypertensionJ. Chinese Journal of Hypertension, 1994, 2(2). DOI: 10.16439/j.cnki.1673-7245.1994.02.016
Citation: WANG Xianyan, GONG Lansheng, GUO Jizhen, WANG Xiaoming, LIU Yuhui, YE Xuying, ZHANG Guoyuan, YANG Peilin. Multicenter Parallel Study of Amlodipine Versus Nitrendipine in Treatment Essential HypertensionJ. Chinese Journal of Hypertension, 1994, 2(2). DOI: 10.16439/j.cnki.1673-7245.1994.02.016

Multicenter Parallel Study of Amlodipine Versus Nitrendipine in Treatment Essential Hypertension

  • In a multicenter, randomized l sing1e blind and para11e1 study, 488 patients with essential hypertension were completed 4 week t1’eatment with amlodipine 0r nitrendipine. It showed that the response rates of amlodipine were 90. 4% and it was higher than that of nitrendipine. Its adverse effets were fewer than those of nitrendipine. In conclusi0n,amlodipine is a safe and effective antihypertensive agent. Its once daily (5 1Omg) dosage makes it very c0nvenient for patients.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return